NCT/Study#
NCT05482516 /
ML43975
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
DISEASE GROUP:
Gastrointestinal (GI) Oncology
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
